WuXi AppTec Sets Out Board and Committee Structure

WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has provided an update.

WuXi AppTec Co., Ltd. has announced the current composition of its board of directors, detailing a mix of executive, non-executive and independent non-executive directors, with Ge Li serving as chairman and chief executive officer. The board structure underscores a governance framework that balances management leadership with independent oversight, which is important for investor confidence and regulatory compliance in the Hong Kong market.

The company also outlined the membership of its four key board committees: Strategy, Nomination, Audit and Remuneration and Appraisal, each chaired by senior board members with a blend of executive and independent directors. This committee configuration is designed to strengthen strategic decision-making, enhance transparency in financial and audit matters and ensure robust processes for executive remuneration and board nominations, supporting long-term corporate governance and stakeholder interests.

The most recent analyst rating on (HK:2359) stock is a Buy with a HK$150.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

More about WuXi AppTec Co., Ltd. Class H

WuXi AppTec Co., Ltd. is a China-based joint stock company listed in Hong Kong that operates in the pharmaceutical and life sciences services sector. The company is led by Chairman and CEO Dr. Ge Li alongside co-chief executive officers Dr. Minzhang Chen and Dr. Steve Qing Yang, reflecting a management structure focused on scientific leadership and global healthcare service offerings.

Average Trading Volume: 4,684,003

Technical Sentiment Signal: Buy

Current Market Cap: HK$339.2B

See more insights into 2359 stock on TipRanks’ Stock Analysis page.